tiprankstipranks

Erle Mast Insider Profile

4 Followers
Erle Mast, EVP & CFO at Clovis Oncology, holds 135.58K shares in Clovis Oncology (Ticker: CLVSQ), holds ― shares in Sienna Biopharmaceuticals (Ticker: SNNAQ), holds 3.03K shares in Zogenix (Ticker: ZGNX).
tipranks
Erle Mast

Erle Mast
Clovis Oncology (CLVSQ)
EVP & CFO

Ranked #15,312 out of 98,624 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

+59.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Erle Mast does not currently own shares as a corporate insider.
A breakdown of Erle Mast's holdings

Insider Roles

Sienna Biopharmaceuticals
(SNNAQ)
Director
Roles that Erle Mast holds in companies

Most Profitable Insider Trade

Stock:
Receptos
(RCPT)
Rating:Informative Buy
Date:Mar 17, 2014 - Mar 17, 2015
Return:+193.10%
The most profitable trade made by Erle Mast

Erle Mast's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CLVSQ
Clovis Oncology
Nov 03, 2015
Uninformative Sell
316.67K
$2.03K
Sienna Biopharmaceuticals
Director
ZGNX
Zogenix
Feb 03, 2022
Uninformative Sell
32.54K
$80.76K
RCPT
Receptos
Aug 27, 2015
Uninformative Sell
$0.00
SOMX
Somaxon Pharmaceuticals
List of latest transactions for each holding click on a transaction to see Erle Mast's performance on stock

Erle Mast insider profile FAQ

What is the percentage of profitable transactions made by Erle Mast?
The percentage of profitable transactions made by Erle Mast is 33%.
    What is the average return per transaction made by Erle Mast?
    The average return per transaction made by Erle Mast is 59.40%.
      What stocks does Erle Mast hold?
      Erle Mast holds: CLVSQ, SNNAQ, ZGNX, RCPT, SOMX stocks.
        What was Erle Mast’s latest transaction?
        Erle Mast latest transaction was an Uninformative Sell of $316.67K.
          What was Erle Mast's most profitable transaction?
          Erle Mast’s most profitable transaction was an Informative Buy of RCPT stock on March 17, 2014. The return on the trade was 193.10%.
            What is Erle Mast's role in Clovis Oncology?
            Erle Mast's role in Clovis Oncology is EVP & CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.